To examine the contribution of arachidonic acid (AA) metabolites to the maintenance of cutaneous vasomotor tone after thermal injury, enzyme inhibitors were topically applied to the hamster cheek pouch before and after a spot burn. By use of video microscopy, blood flow was measured in adjacent arterioles that supplied the injured site. Ringer's solutions containing no drug (vehicle), indomethacin (cyclooxygenase inhibitor), BW755c (cyclooxygenase/lipoxygenase inhibitor), or ketoconazole (lipoxygenase/cytochrome P450 inhibitor) continuously suffused the entire tissue. There were no effects of these drugs on preburn blood flow at concentrations that blocked the vascular effects evoked by topical AA. In all groups, blood flow transiently increased after burn and thereafter decreased to levels that were altered by treatment. These results could not be attributed to alterations in vascular reactivity because neither the burn nor the drugs altered the vasodilation evoked by adenosine or prostacyclin. Relative to Ringer's, indomethacin had no effect, BW755c caused vasodilation, and ketoconazole caused vasoconstriction, which suggests that cytochrome P450 products might be vasoactive mediators in injured tissue. Therefore, purified synthetic compounds were compared with known vasodilators. The potency was prostacyclin > 12R-hydroxyeicostetraenoic acid > adenosine = 5,6 epoxyeicosatrienoic acid > AA, which supports the hypothesis that AA can be the source of a novel class of nonprostaglandin vasodilator compounds. In addition, at least one of the vasodilator responses was stereospecific. Nevertheless, the exact explanation for the differential effects of AA inhibitors on postburn blood flow is unknown.
BURNS TYPICALLY look like bull's-eyes: the most pronounced injury is centrally located and surrounded by zones with progressively less injury.1 The acute microcirculatory sequelae include a central region with focal necrosis and coagulation that is enclosed by progressive zones with leukocyte infiltration and ischemia (or stasis) and finally, grossly normal tissue.1 One goal of therapeutic regimens is to prevent enlargement of the ischemic zones.
Arachidonic acid (AA) metabolites have been detected in exudates, fluids, and skin of thermally injured animals and humans, and some AA inhibitors minimize dermal ischemia after a burn. These observations have led to the hypothesis that AA metabolites influence the changes in blood flow after burns.2 Nevertheless, there is no consensus on the efficacy of AA inhibitors in thermal injury.3 The controversy probably reflects, in part, the complicated interactions between the several systemic and local factors involved in the injury response (e.g., physical effects of heat, immune factors, toxins, and biologically active amines, peptides, etc.), as well as nonspecific effects produced by the systemic administration of AA inhibitors.'
It is now known that AA can be oxidatively metabolized by three separate enzymatic pathways (i.e., cyclooxygenase, lipoxygenase, and cytochrome P450 monoxygenase) to an array of substances that can influence tissue blood flow.4The vasoactivity of products from the first two pathways (i.e., prostaglandins, prostacyclin, thromboxane, leukotrienes) is well known, but products from the cytochrome P450 pathway can also have powerful effects on tissue perfusion,6'7 so these potential actions cannot be overlooked. For this reason, it may be unwise to attribute the actions of any single class of inhibitors to any single class of AA metabolites. In addition, inhibitors of a single pathway of AA metabolism cannot prevent the unused substrate from being diverted into competing enzymatic pathways, nor can they prevent the actions of AA metabolites that are already formed. 8 Compounds that inhibit the cyclooxygenase and lipoxygenase pathways of AA metabolism (e.g., BW755c) should prevent the synthesis of thromboxane and leukotriene vasoconstrictors,8-11 as well as inhibit the activation and migration of leukocytes into injured tissue12 and thereby the release of several leukocytederived cytotoxic factors (e.g., 02 free radicals, proteolytic enzymes, etc.). Thus BW755c or similar drugs, might have an especially prominent effect on the ischemia that accompanies thermal injury, but this idea has not been previously tested.
The overall objective of this study was to compare the efficacy of AA inhibitors for preventing burn-induced ischemia. The purpose of the first series of experiments was to determine the effects of three functionally and structurally dissimilar inhibitors of AA oxidation on arteriolar blood flow after a thermal injury: BW755c (dual cyclooxygenase/lipoxygenase inhibitor), indomethacin (cyclooxygenase inhibitor), and ketoconazole (dual lipoxygenase/cytochrome P450 inhibitor). To minimize systemic effects, all drugs were locally administered. The purpose of the second series of experiments was to verify that the apparent effects of the AA inhibitors could not be attributed to nonspecific drug effects or to nonspecific alterations in vascular reactivity. The results from the first two series of experiments suggested that products from the cytochrome P450 pathway of AA metabolism might modulate tissue blood flow after thermal injury. Therefore, the purpose of the third series of experiments was to test whether cytochrome P450 metabolites were vasoactive in this preparation. To accomplish the overall objective, a simplified preparation of thermal injury was developed: the hamster cheek pouch microcirculation was observed for 1 to 2 hr after a small fraction of that tissue was spot burned. This preparation was selected because it is easily accessible and because it is representative of the cutaneous microcirculation, which is usually the first tissue damaged by thermal insult. The advantage of this experimental approach is that the effects of both the injury and the enzyme inhibitors are restricted to a well-defined area of the peripheral circulation, so that maladaptive secondary responses of systemic nature are minimized. In addition, the action of the drugs could be directly observed at the immediate site of action in the microcirculation.
Methods
General. Before the experiments, male hamsters (90 to 150 g) were fed a standard laboratory diet ad libitum. The animals were initially anesthetized with an intraperitoneal injection of sodium pentobarbital (Nembutal, 70 mg/kg) and maintained on a continuous intravenous infusion (0.5 ml/hr) of 20% pentobarbital in 5% dextrose. Rectal temperature was continuously monitored (YSI 401, Yellow Springs, OH) and maintained at 360 to 380 C by a heat lamp. The femoral artery and vein were cannulated. The arterial cannula was connected to a Gould-Statham P231D transducer for measurement of systemic arterial blood pressure. Respiration was spontaneous through a tracheal cannula on room air supplemented with 100% 02. The blood gas measurements (n = 8) averaged 381 + 28 mm Hg for Po2, 42 + 3 mm Hg for Pco2, and 7.31 + 0.03 for pH, arterial blood pressure ranged from 100 to 120 mm Hg, and the animals remained stable for more than 6 hr. With room air alone, arterial blood P02, Pco2, and pH were measured on a Radiometer Analyzer (Copenhagen). These values (n = 5) averaged 77 ± 16 mm Hg, 41 + 4 mm Hg, and 7.34 ± 0.02. Arterial blood pressure typically ranged from 70 to 90 mm Hg, and the animals remained relatively stable for 3 to 5 hr.
The cheek pouch was carefully cleaned, everted, and divided into a flattened sheet. 13 After securing the lower membrane over a viewing port on a specially designed animal board, the areolar connective tissue was removed to expose the underlying microvascular network. 13 Throughout the surgical and experimental procedure, the tissue was continuously superfused (5 to 10 ml/min) with heated Ringer's-bicarbonate buffer solution consisting of (mM): NaCl 131.9, KCl 4.7, CaCl2 2.0, MgSO4 7H2O 1.2, and NaHCO3 20.
Solution gas tensions and pH were maintained by vigorous bubbling with a gaseous mixture of 5% CO2 and 95% N2 in glass chambers encased in water jackets at 370 C. The chambers were connected to the tissue perfusion chamber of the animal board by thick-walled rubber tubing. The preparation was secured to the stage of a Leitz Laborlux microscope and transilluminated (50W halogen lamp). The microcirculation was visualized through a long working distance objective (Leitz L32x, 0.4 numerical aperture or Leitz L20x, 0.32 numerical aperture) and condenser (Leitz Li1, 0.6 numerical aperture). The optics were aligned in accordance with Kohler's principle to enhance contrast. The image was transmitted to a periodic differential detector velocimeter (Op-Tech, Shreveport, LA) and conveyed by a Panasonic color video camera (Model WV3890B, Seacaucus, NJ) to a For-A Video Timer (Model VTG-33; Tokyo), For-A Video Microscalar (Model IV-550; Tokyo), and JVC color monitor (Model 7280UM; Tokyo).
Microcirculatory hemodynamics. Arteriolar diameter was measured on-line by positioning two parallel lines on a microvessel's image with the video micrometer. An analog voltage proportional to the distance separating the two lines was continuously recorded. The system was calibrated with a stage micrometer to an accuracy of 1 pm.
Red blood cell velocity was measured with a periodic differential detector.14 Briefly, an image of a microvessel was projected onto an array of photodiodes. Current from the oddand even-ordered diodes was summed, and a signal proportional to the difference between the two currents was produced by a differential amplifier. That signal was proportional to red blood cell velocity.'4 This instrument was calibrated in vitro by moving a film with dried red cells past the photodiode array at a known velocities. Blood flow was calculated from the product of vessel crosssectional area (calculated from the digitized diameter data) and mean blood flow velocity (calculated from the digitized measured velocity divided by a 1.6 proportionality factor).
All physiologic variables were continuously recorded on a six-channel polygraph (Gould Model 200). , a leukotriene receptor antagonist. In most experiments, these substances were added to the suffusate 10 to 30 min before the thermal injury, and remained in the suffusate for the duration of the experiment. In a few experiments (see Results) the substances were administered after the injury. The various solutions were made each day. Thermal injury was produced outside the viewing field by spot burning the tissue for 1 to 2 sec with a circular iron rod (diameter = 1 mm) that had been heated to 3250 to 4000 C in a Bunsen burner. The injury was produced in a region that mostly contained capillaries and relatively few small arterioles and venules. These sites were typically found distal to an arteriolar bifurcation, approximately equidistant between the two arteriolar branches. Blood flow was calculated proximal to the bifurcation in an arteriole that was the main supply for the injured tissue. The measurement site was located in tissue adjacent to the injury that appeared grossly normal on direct microscopic observation.
At the end of some experiments, the tissue was fixed with 4% buffered formalin in situ. The specimens were embedded in mounting resin and then stained with hematoxylin and eosin, according to standard techniques in the Department of Pathology, University of Tennessee.
Series 2 experiments. The purpose of these experiments was
to test whether the various AA enzyme inhibitors and/or the thermal injury nonspecifically altered vascular reactivity. After the postsurgery stabilization period, a measurement site was selected according to the aforementioned criteria. A 5 to 50 jil bolus of Ringer's solution containing either adenosine (Sigma, St. Louis), AA (Nu-Chek Prep; Elysian Park, MN), or prostacyclin (gift from Dr. S. Moncada at Burroughs Wellcome, Beckenham, Kent, England) was topically applied to the microcirculation. These solutions were made each day. The concentration of each agonist within Ringer's solution was empirically adjusted to evoke submaximal vasodilation. The typical response was a transient vasodilation (>30% increase) and hyper-emia (> 60% increase) that returned to the pretreatment baseline within 2 to 4 min. In individual animals, paired data were collected at a given concentration for one or more of the vasodilator compounds before and after thermal injury. The data were rejected if paired measurements were not obtained or if no vasodilator response could be evoked because no response indicated the absence of spontaneous vasomotor tone.
Seres 3 experiments. The purpose of these experiments was to test whether cytochrome P450 metabolites of AA were vasoactive in the cheek pouch microcirculation. The cytochrome P450 metabolites 5,6 epoxyeicosatrienoic acid (5, 6 EET) and 12R-hydroxyeicosatrienoic acid (HETE), and the lipoxygenase metabolite 12S-HETE, were prepared by chemical synthesis at the University of Texas and purified by high-performance liquid chromatography at Vanderbilt University with use of published techniques.' -19 The samples were dissolved in degassed ethanol and shipped on dry ice by overnight express to the University of Tennessee, where the microcirculatory experiments were performed the following day.
After a 30 to 60 min postsurgery equilibration period, a measurement site was selected on an arteriole whose resting diameter typically averaged 30 to 60 jim and was stable for at least 10 to 20 min. To test for the presence of spontaneous vasomotor tone, 5 to 10 jIl of solutions containing either adenosine in Ringer's solution (1 to 3 mg/ml), prostacyclin in Ringer's solution (0.01 to 0.1 mg/ml), or AA in ethanol (1 to 3 mg/ml) were topically applied to the cheek pouch. The concentration of each agonist was empirically adjusted to produce a transient increase in arteriolar diameter and calculated arteriolar blood flow and a return to the baseline within a 3 to 8 min time interval. After observing the response. to a particular agonist, the vehicle (either Ringer's or ethanol) was topically applied.
If the vehicle evoked a measurable response, the data were rejected and a new measurement site was located.
Thereafter, 5 to 10 jil solutions containing either 12R-HETE, 12S-HETE, or 5,6 EET in ethanol were applied to the preparation with the identical sequence of steps. Because of the limited amount and lability of these compounds, their actions were tested only after the viability and reactivity of the preparation had been established with the commercially available compounds prostacyclin, adenosine, or AA. Since the molecular weights of AA, prostacyclin, adenosine, 12R-HETE, 12S-HETE, and 5,6 EET are similar (approximately 300), the concentrations of all compounds were expressed in units of micrograms per milliliter for comparison of potency.
Statistical analysis. The vascular responses to the various experimental treatments or vasodilator agonists were expressed relative to steady-state baseline arteriolar diameter and calculated blood flow values that were observed in the 10 to 20 min period immediately preceding the experimental period. All data were expressed as the mean + SE. Some comparisons were paired and most treatments were randomized. Differences between the slopes of regression lines were tested with analysis of covariance. Differences between mean values were determined with paired or unpaired t tests. Significance was assessed at the 95% confidence interval.
Results
Qualitative histologic observations. The hamster cheek pouch is one of the most thoroughly studied microcirculatory preparations. There are numerous references to its anatomy and histology (see Duling13 for review), so a detailed discussion is not warranted in this context. In general, the cheek pouch resembles cutaneous tissue composed of four layers: dense fibrous Vol. 77, No. 5, May 1988 connective tissue, stratified squamous epithelium, skeletal muscle, and loose areolar connective tissue. The tissue is supplied by a rich anastamotic microvascular network.
Within 1 to 2 hr after a spot burn, there were characteristic histologic changes in the specimen that included three distinct zones: focal coagulation and necrosis at the site of injury, a surrounding area of ischemia and stasis, and grossly normal tissue. The diameter of the focal necrotic area averaged 2118 + 174 ptm in 13 animals. The bull's-eye appearance of this thermal injury resembles that of other types of clinical and experimental thermal injury.1-3
There was no obvious difference in the histologic appearance of the burned specimens that were pretreated with indomethacin and vehicle. However, the BW755c-treated specimen showed the fewest ischemic changes, i.e., minimal separation between the adjacent tissue layers. In this group, an abrupt line demarcated the coagulative and ischemic zones. On the other hand, the ketoconazole-treated tissue showed the most prominent ischemic changes, and there was considerable overlap between the coagulative and ischemic zones.
There was no obvious effect of the various drugs on the numbers of granulocytes in the injured tissues: all specimens contained 5 to 8 granulocytes per highpower field. However, it was difficult to clearly distinguish between granulocytes, mast cells, and cellular fragments with this staining technique.
Series 1 experiments: effects of AA inhibitors on resting blood flow before, during, and after thermal injury.
There were no consistent effects of a continuous suffusion containing indomethacin (10 Wg/ml), BW755c (10 ,ig/ml), or ketoconazole (7 [.g/ml) on arteriolar hemodynamics in unburned tissue (table 1). This suggests that AA metabolites are not important After a steady-state baseline was maintained for 10 to 30 min with vehicle only in the suffusate, the various drugs were added to the suffusate to a steady-state concentration. These data were collected 10 to 20 min later after the suffusate had fully equilibrated with the tissue. The drugs remained in the suffusate until the end of the experiment. Throughout the procedure, systemic arterial blood pressure typically ranged from 100 to 120 mm Hg and was not altered by the local application of these compounds. Values are mean t SE. suffused with a solution containing bicarbonate-buffered Ringer's (vehicle) or indomethacin (10 pg/ml), there was a transient vasodilation followed by declines to postburn baselines within 40 min that were indistinguishable from the respective preburn baselines. With BW755c in the suffusate (10 ,ug/ml), postburn arteriolar diameter and blood flow were significantly higher than the preburn values. The effects were opposite with ketoconazole in the suffusate ti pg/ml). These results
show that pretreatment with various AA inhibitors can influence postburn vasomotor tone. n = number of animals; SE = average within group standard error.
determinants of blood flow in this tissue under control conditions. Figure 1 shows the time-dependent changes in arteriolar diameter and blood flow after burn injury in four groups of animals. All drugs were added to the suffusate 10 to 30 min before the burn and remained in the suffusate until the end of the experiment. For comparison between treatments, the hemodynamic variables were normalized to the respective preburn steady-state baselines and expressed as percent of control. In all groups, the burn caused a transient increase in arteriolar diameter and blood flow for 5 to 10 minm this increase was smallest in the ketoconazole group. The average standard errors for each curve are shown on the figure. After the transient response, blood flow gradually declined to a new, relatively stable baseline after 30 to 40 min.
Within 10 min after the burn, the rates of decreases in blood flow vs time were significantly linear in each group. These relationships were described by the regression equations:
Indomethacin; y = ( -1.9 + 0.2)x + 188; r = .95
(2) BW755c; y = (-0.7 + 0.3)x + 179; r = .58 (3) Ketoconazole; y = (-1.2 + 0.1)x + 109; r = .94 (4) where x = time after the burn (min); y = calculated blood flow (% control). There was a significant difference between the slopes of the regressions, as determined by analysis of covariance.
Within 30 to 40 min after the burn, calculated blood flow had essentially returned to the preburn baselines in the vehicle and indomethacin groups (96 + 10% of control or 111 + 14% of control), and arteriolar diameter changes were similar. However, there was wide variation in individual animals. In the vehicle group (n = 20), postburn calculated blood flow ranged from 8% to 85% of control in seven of 20 animals and greater than 140% of control in four of 20 animals. Postburn arteriolar diameter ranged from 90% to 120% ofcontrol in 16 of 20 animals.
In the indomethacin group (n = 5), postburn blood flow ranged from 60% to 85% of control in three of five animals and from 100% to 130% of control in two of five animals. Postburn arteriolar diameter ranged from 94% to 118% of control in five of five animals. Since the magnitude and variability of the burn-induced microcirculatory changes were similar with vehicle and with indomethacin pretreatment, cyclooxygenase products are probably not important determinants of postburn blood flow.
In the BW755c treatment group (n = 10), arteriolar diameter at 30 to 40 min after the burn was significantly elevated (118 + 7% of control). Calculated blood flow tended to be elevated above its baseline (163 + 27% of control), but this change was not significant at the 95% confidence level. The lack of a significant difference in the blood flow value, despite the significant vasodilation, probably reflects the destruction of the downstream microvascular network by the thermal injury.
The variabilities in the burn-induced diameter and blood flow changes were less with BW755c than with indomethacin or vehicle. With BW755c treatment, postburn blood flow was greater than 140% in six of 10 animals and 80% to 110% of control in four of 10 animals. Postburn arteriolar diameter was greater than 100% in nine of 10 animals.
The effects of ketoconazole were the opposite of those of BW755c, and the variabilities in the burninduced changes in diameter and blood flow were less.
Postburn blood flow was significantly below its baseline (55 + 5% of control). This value was significantly lower than that with any other treatment. In this treatment group, postburn arteriolar diameter was reduced Vol. 77, No. 5, May 1988 to 80% to 90% of control in five of five animals and blood flow was decreased to 30% to 60% of control in five of five animals. Figure 2 compares the effects of BW755c and ketoconazole on blood flow when these substances were applied before and after the burn. Neither BW755c nor ketoconazole had detectable effects on resting blood flow in the unburned tissue (see also table 1), but there were large and variable effects afterward. When BW755c was added to the suffusate 30 to 100 min after burn, blood flow increased to 185 ± 53% of control in five of eight animals. However, in three of eight animals, blood flow did not change or slightly decreased with BW755c treatment. Overall, postburn blood flow averaged 17 + 5 nl/sec without BW755c and 30 + 14 nl/sec with BW755c. Even though the postburn application of BW755c generally caused vasodilation, this apparent difference was not statistically significant. The implication of these results is that BW755c either blocked the synthesis of a cyclooxygenase/lipoxygenase vasoconstrictor or favored the formation of a vasodilator derived from the third pathway of AA metabolism.
The response evoked by BW755c was not associated with the time of postburn treatment. BW755c was added to the suffusate 68 + 9 min after the burn and there was no systemic correlation between the response and the time of treatment AFTER BURN FIGURE 2. The effect of BW755c (10 pug/ml) or ketoconazole (7 ,ug/ml) on arteriolar blood flow when these substances were applied before or after the thermal injury. Neither substance had a measurable effect when applied to the uninjured tissue. When applied after the injury, BW755c tended to evoke vasodilation, but the response was variable and not significant. In contrast, ketoconazole applied after the injury produced significant vasoconstriction. These results show that BW755c and ketoconazole do not alter blood flow under control conditions. However, when these substances were topically applied after the injury, they produced effects on vasomotor tone that were substantially similar to the effects illustrated in figure 1. blood flow decreased to 58% of control when the drug was applied 32 min after the burn, but in another animal, blood flow increased to 123% of control with treatment 30 min after the burn. At the opposite extreme, blood flow increased to 396% of control with treatment 81 min after the burn, but in another animal, decreased to 74% of control with treatment 93 min after the burn.
It is unlikely that postburn treatment with BW755c unmasked the action of vasoactive leukotrienes because a leukotriene receptor antagonist, FPL-55712 (10 ,uglml), had no effect on postburn blood flow in two animals.
In contrast to the eflects of BW755c, ketoconazole caused constriction in five of five animals that were treated after burning (figure 2). After the burn, calculated blood flow averaged 23 + 5 nl/sec before and 15 + 3 nl/sec after treatment. This difference was significant.
Ketoconazole produced constriction in the damaged tissue regardless of the time of treatment. In various trials, the drug was added to the suffusate 30 to 123 min after the burn (average = 74 + 15 min postburn). Blood flow decreased to 82% of control with treatment 30 min after the burn and decreased to 75% of control with treatment 123 min after the burn. The implication of these data is that ketoconazole blocked the formation of lipoxygenase/cytochrome P450 vasodilators or favored the formation of cyclooxygenase vasoconstrictors.
The effects of a structurally dissimilar compound, SKF525A, were evaluated in two animals. This substance has an action that is reportedly similar to that of ketoconazole, i.e., it acts as a dual inhibitor of the lipoxygenase/cytochrome P450 pathways.5' [20] [21] [22] SKF525A was added to the suffusate (10 pLg/ml) 30 min after the burn and blood flow decreased. However, these data probably have little meaning because SKF525A also caused vasoconstriction before the burn at concentrations as low as 2 p,g/ml. Therefore, no further experiments were performed with this compound.
In summary, the burn evoked transient vasodilation, followed by a slow decline to a postburn value that was dependent on the type of treatment. Compared with Ringer's vehicle, blood flow was higher with BW755c, lower with ketoconazole, and not affected by indomethacin. None of the drugs had consistent effects before thermal injury. 
BEFORE BURN AFTER BURN
FIGURE3. The vascular effect evoked by AAbefore and after the burn. Each animal was exposed to all treatments in sequence. A continuous topical application of AA (3 ,ug/ml) for 10 to 15 min caused a transient initial vasoconstriction of variable magnitude that was followed shortly thereafter by a sustained vasodilation. This response was prevented with BW755c (10 gWg/ml) before, but not after, the burn. If there was no breakthrough of cyclooxygenase inhibition, this observation suggests that the burn may have altered the pathway of AA metabolism.
fusion with BW755c. Before the burn, arteriolar diameter was 40 ± 3 Km and blood flow was 15 ± 4 nl/sec in five animals (left panel). A continuous suffusion containing 3 Kg AA/ml caused transient vasoconstriction and then steady-state increases in diameter to 55 3 pKm (139 + 7% of control) and in blood flow to 38 + 6 nl/sec (278 ± 43%). A biphasic vascular effect evoked by AA has been previously observed in this tissue. 23 After washout of AA, BW755c was added to the suffusate (10 p,g/ml) for the remainder of the experiment. There were no significant changes in diameter and blood flow, which averaged 38 ± 4 ,im and 13 2 nl/sec (95 ± 2% and 91 + 8% of the original pretreatment baseline levels). During BW755c, AA was again suffused over the tissue, and as expected, there was no response. When AA was removed from the suffusate (BW755c treatment continued), diameter and blood flow remained unchanged (39 ± 4 Km and 13 ± 3 nl/sec). Thus, a continuous suffusion of BW755c completely eliminated the response evoked by exogenous AA before the burn. The implication is that cyclooxygenase or lipoxygenase metabolites mediated the vasoactive effect of AA under these conditions. Figure 3 , ight, shows responses in the same five animals after burning during BW755c. Postburn arteriolar diameter and blood flow were slightly, but not significantly, higher (41 ± 4 Km and 15 ± 2 nl/sec). However, when AA was reapplied, there was a slow, sustained vasodilation to 47 ± 5 p,m and hyperemia to 27 + 8 nl/sec. When AA was removed from the suffusate, the baseline was restored within 30 min.
Thus, BW755c did not block AA evoked vasodilation after the burn. The implication is that cyclooxygenase or lipoxygenase metabolites could not account for the effect of AA in this situation unless there was a breakthrough or override of enzyme inhibition.
To test whether high levels of AA might override the effect of the cyclooxygenase enzyme inhibitors, the vascular responses evoked by bolus applications of AA were determined. Figure 4 shows paired responses evoked by AA with no drug and with BW755c (10 ,gml) in the suffusate in two animals. With no drug, a 10 ,u bolus containing 12.5 ,ug AA (1.25 mg AA/ml) initially caused vasoconstriction followed by vasodilation. Within 6 min. arteriolar diameter and blood flow had returned to the pretreatment baseline. Thereafter, BW755c was added to the suffusate. After a 10 min equilibration period, AA was reapplied to the tissue, but no response was observed. Figure 4 also shows paired responses evoked by AA with no drug and with indomethacin (10 ,ug/ml) in the suffusate in three animals. With no drug, a 10 , l bolus containing 20 Kug AA (2 ,ug AAlml) evoked a transient vasodilation that returned to the pretreatment baseline within 6 min. After indomethacin was added to the suffusate, AA evoked no response. Within each treatment group, each animal was exposed to a 10 p.l bolus of 10% ethanol in Ringer's containing AA (1 to 2 mg/ml) in the presence and absence of the drugs. A bolus application of the vehicle alone evoked no detectable response (data not shown). In the uninjured tissue, the vehicle plus AA caused vasodilation that was blocked with either BW755c (10 pg/mI) or indomethacin (10 pug/ml). If vascular reactivity was not altered, this observation suggests that the effects of the enzyme inhibitors before and after the burn, as illustrated in figures 1 to 3, could not be explained by a breakthrough of cyclooxygenase inhibition. TIME (min after adenesine bolus) FIGURE 5 . The effect of the burn on vascular responses evoked by exogenous adenosine. Within each treatment group, each animal was exposed to a 10 to 25 ,ul bolus of a Ringer's solution containing adenosine (0.05 to 0.5 mg/ml) before and after the burn. Adenosine evoked vascular responses that were not affected by the burn or by the drug treatments. This experiment shows that neither the burn nor the drugs altered the ability of the arterioles to dilate in uninjured regions of the tissue. A corollary is that ischemia can be prevented in unburned tissue.
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Thus, a continuous suffusion containing 13W755c or indomethacin blocked the vasodilation evoked by exogenous AA. If these experimental techniques did not alter vascular reactivity, the implication is that a breakthrough of cyclooxygenase inhibition does not explain the postburn vasodilation induced by BW755c (figures 1 and 2), the lack of effect of indomethacin on postburn blood flow (figure 1), or the inability of BW755c to block AA-induced vasodilation after the burn (figure 3).
To examine whether the burn or the drugs altered vascular reactivity, responses to the structurally dissimilar vasodilators, adenosine and prostacyclin, were determined. Figure 5 shows the effect of the drugs on responses evoked by a 10 to 20 gl bolus containing 0.2 to 2 ,ug adenosine. Within each treatment group, paired responses were collected before and after the burn. None of the drugs had a conspicuous effect on adenosine-induced vasodilation before or after the burn. prostacyclin. The implication of these results is that BW755c and ketoconazole unmasked the action of a cytochrome P450 metabolite that was responsible, in part, for the maintenance of postburn vasomotor tone.
Series 3 experiments: comparative vascular actions of novel metabolites derived from the cytochrome P450 pathway of AA metabolism in unburned tissue. Figure 7 shows arteriolar diameter and calculated arteriolar blood flow after the topical application of adenosine, AA, and 5,6 EET. Mean baseline diameters averaged 37 to 42 ,um in the three populations of animals before application of the substances and stabilized at these same values afterward. These baseline diameters were not significantly different between groups.
Immediately after a 5 to 10 il bolus containing 5 1 ,ug adenosine was added to the suffusate, diameter and calculated blood flow increased. The peak values were 140 + 6% of control and 204 22% of control after 40 sec. Thereafter, both variables steadily declined and reached the pretreatment levels within 100 sec after application.
A 5 to 10 i.il bolus containing 6 + 1 ,ug 5,6 EET caused a rapid rise in diameter and calculated blood flow to peak values that averaged 125 6% and 167 ± 16% of control. Thereafter, both variables returned to the pretreatment levels, but the decay was slightly slower than that after adenosine application. By 240 sec 1192 1 50 Û u _ . after 5,6 EET application, arteriolar diameter averaged 110 + 6% of control and calculated blood flow averaged 131 + 10% of control. For comparison, the values after adenosine application averaged 98 + 3% and 94 + 3% of control at the same time increment. Thus, the vasodilation evoked by 5,6 EET was slightly smaller in magnitude but more prolonged than the response evoked by adenosine. Approximately 100 sec after a 5 to 10 ,ul bolus containing 16 + 6 pig of AA was topically applied to the tissue, arteriolar diameter and calculated blood flow increased to 124 + 5% and 162 ± 29 of control. For the next 2 min, diameter and blood flow remained near these values. Within the subsequent 3 to 4 min, diameter and blood flow slowly declined to the pretreatment levels.
Thus, a racemic mixture of 5,6 EET evoked a vasodilator response that was similar to that evoked by an equivalent amount of adenosine applied under similar conditions. At least twoto threefold more AA was required to evoke a comparable response. Therefore, it is reasonable to conclude that 5,6 EET is a vasodilator with a potency comparable to that of adenosine, and greater than that of AA, in unburned tissue. Figure 8 compares the vasodilator potency of another cytochrome P450 metabolite, 12R-HETE, with that of adenosine, prostacyclin, and the lipoxygenase metabolite 12S-HETE. In these four populations, baseline arteriolar diameter ranged from 31 to 45 jim and was not significantly different between the various groups. An 8 to 10 jil bolus containing 25 jig adenosine caused immediate vasodilation. After 60 sec, diameter peaked at 139 + 6% of control and calculated blood flow peaked at 275 33% of control. Thereafter, both variables gradually returned to their respective baselines.
The time course of vasodilation evoked by 25 jig 12R-HETE was similar to that of adenosine, but the magnitude was greater. After 60 sec, diameter and blood flow had already risen to 159 ± 30% and 383 ± 131% of control. Nevertheless, the responses evoked by adenosine or 12R-HETE were a small fraction of that evoked by prostacyclin.
Under these bioassay conditions, a 5 to 10 ,ul bolus containing only 0.34 ± 0.21 jig prostacyclin caused a peak diameter increase (176 ± 13% of control) that was similar to that evoked by nearly 100-fold more 12R-HETE (169 ± 42% of control). Furthermore, the peak blood flow change after prostacyclin (776 ± 214% of control) tended to exceed that of 12R-HETE (504 ± 25% of control). At higher doses (.1 jig), prostacyclin often caused irreversible vasodilation and/ or changes in systemic arterial pressure.
Thus, it is reasonable to conclude that the cytochrome P450 metabolite 12R-HETE is a vasodilator whose potency is greater than that of adenosine and less than that of prostacyclin, whereas the lipoxygenase metabolite 12S-HETE is inactive in unburned tissue.
In summary, the data in figures 7 and 8 show that at least two metabolites derived from the cytochrome P450 pathway of AA metabolism caused vasodilation according to the potency order: prostacyclin > 12R-HETE > adenosine > 5,6 EET > AA.
Discussion
The major new findings from this study are that: (1) ketoconazole and BW755c produce opposite effects on resting blood flow after thermal injury, but neither substance has an effect on resting blood flow before the injury, (2) BW755c blocks AA-induced vascular responses before, but not after, thermal injury, (3) 5,6 EET and 12R-HETE, which are derived from the cytochrome P450 pathway of AA metabolism, are potent vasodilators in unburned tissue. The implication is that AA metabolites could mediate or modulate the acute changes in blood flow that accompany thermal injury to the cutaneous microcirculation. However, there are inherent assumptions in this experimental approach and certain features of the experimental design that deserve comment.
Limitations of the experimental design. Heat transfer to tissue is a complex process. The application of a heated metal object to the exposed hamster cheek pouch might not produce the same type of injury as, for example, scalding water on the keratinized epithelium of the human arm.1' 2 In addition, there is no question that a 1 to 2 sec application of a red-hot iron probe is far from a perfectly controlled stimulus. Furthermore, even if the noxious stimulus had been perfectly controlled, it would be reasonable to expect a wide vari- ation in the acute microcirculatory response because the lesion was not located at exactly the same position within the microcirculatory network in each individual animal. Indeed, when the tissue was suffused with vehicle or with vehicle and indomethacin, there was a marked variability in the burn-induced blood flow change (see Results). Interestingly, however, the expected variability was conspicuously lower in the groups treated with either BW755c or ketoconazole (see Results). This observation alone is consistent with some role for AA metabolites in the response. The acute changes in blood flow should depend on the size of the thermal injury. In this study, the diameter of the focal necrotic zone at the burn site averaged 2.1 + 0.1 mm, while the typical diameter of the entire cheek pouch was greater than 40 mm. This represents an extremely small injury burden compared with that imposed in other experimental preparations.1-3 It is logical to assume that the microcirculatory response in this present study was mediated primarily by local factors because the size of the burn was relatively small.
A host of different factors participate in the widespread adaptive and maladaptive changes that occur in local tissues and in whole body functions for days, and even weeks, after a severe burn.1 In this present study, the observations were directed at the actions of one class of substances (i.e., AA metabolites) on one physiologic variable (i.e., arteriolar blood flow) over a brief time interval (i.e., 1 to 2 hr) after a burn. For these reasons, these observations should be cautiously extrapolated to other laboratory or clinical situations.
Interpretation. The meaning of these results depends on fundamental assumptions about the specificities of the inhibitors of the various enzymes in the AA cascade. Within the framework of the limitations discussed above, it was hypothesized that locally generated AA metabolites altered tissue blood flow after thermal injury and that this action was unmasked with inhibitors of AA metabolism.
There are at least five tentative explanations for the effect of the enzyme inhibitors on postburn blood flow.
(1) Postburn vasomotor tone was primarily mediated by cyclooxygenase products; the lack of effect of indomethacin shows a breakthrough of cyclooxygenase inhibition and the vasodilator effect of BW755c implicates a cyclooxygenase vasoconstrictor.
A breakthrough of cyclooxygenase inhibition is unlikely because indomethacin and BW755c each blocked the vascular effects evoked by a burst of high concentrations of AA ( figure 4 ). Furthermore, BW755c blocked the effect of a continuous application of low concentrations of AA before the burn, whereas AA evoked vasodilation, not constriction, in the presence of BW755c after the burn (figure 3). Therefore this hypothesis is rejected.
(2) Postburn vasomotor tone was primarily mediated by a lipoxygenase product because BW755c produced postburn vasodilation and because ketoconazole produced postburn vasoconstriction.
This hypothesis is unlikely, based on the known mechanisms of action of the enzyme inhibitors. BW755c is the prototype of a class of combined cyclooxygenase/lipoxygenase inhibitors and its actions have been well described.8, 10-12 24 In contrast, ketoconazole is an imidazole derivative that is not generally used as an inhibitor of AA oxidation. Nevertheless, ketoconazole is a potent inhibitor of the cytochrome P450 pathway of AA metabolism25 and leukotriene biosynthesis in vitro26 in the concentration range used in these experiments. At higher concentrations, imidazole derivatives generally inhibit a number of enzymes that contain a heme group, e.g., prostacyclin synthetase and thromboxane synthetase. [27] [28] [29] ketoconazole has the potential to inhibit several enzymes in the AA cascade, but at the doses used in this study, its primary effect was probably restricted to the cytochrome P450 monooxygenase and lipoxygenase systems.
Since both BW755c and ketoconazole inhibited the lipoxygenase pathway, but produced opposite effects on postburn blood flow (figures 1 and 2), and since FPL-55712, an antagonist of LTD4 receptors, had no effect on postburn blood flow (see Results), the action of a lipoxygenase product probably does not explain the effect of the enzyme inhibitors on postburn vasomotor tone.
(3) The effects of the enzyme inhibitors represented nonspecific alterations in vascular reactivity.
Adenosine evoked identical responses before and after the burn with or without indomethacin, BW755c, or ketoconazole (figure 5), so it is unlikely that the effects of these compounds on postburn blood flow could be attributed to nonspecific alterations in vascular reactivity. Furthermore, prostacyclin evoked identical responses before and after the burn ( figure 6 ), so the burn, per se, did not restrict vasodilation. Therefore, this hypothesis is rejected.
(4) Changes in postburn vasomotor tone were mediated by an AA metabolite, but that substance was not produced by a cyclooxygenase or lipoxygenase pathway.
This explanation deserves consideration because a novel pathway of AA metabolism has been recognized; those metabolites are potent vasodilator substances in the microcirculation6' 7 that can antagonize thromboxane-induced platelet aggregation.30 In addition, BW755c enhances the formation of these metabolites in vitro,24 which could account for the postburn vasodilation. Moreover, ketoconazole blocks the formation of these metabolites in vitro,25 which could account for postburn vasoconstriction. AA can be enzymatically oxidized by the cyclooxygenase, lipoxygenase, or cytochrome P450 mixedfunction oxidase systems.4 5 15-19 28The importance of products from the first two pathways is well recognized. However, there is comparatively little information on the vascular action of products from the third pathway, even though the substrate (AA) and the enzyme system (cytochrome P450 monooxygenase) are available to virtually every cell in the body.31 The capability to oxidize AA by cytochrome P450 probably exists in vascular smooth muscle,21' 32, 33 but no definite physiologic or pathologic role has been defined. Figures 7 and 8 show that two purified, synthetic products from the cytochrome P450 pathway of AA metabolism (i.e., 5,6 EET and 12R-HETE) caused vasodilation in the hamster cheek pouch microcirculation. These results support the emerging hypothesis that AA is the source of a novel class of vasodilator metabolites.6' 7 This present study is among the first to show the vascular activity of purified synthetic cytochrome P450 metabolites in the intact microcirculation.
To our knowledge, there have been no previous studies showing a prominent biological action of 12R-HETE. Indeed, with few exceptions, most authorities consider that 12-HETE is a biologically inactive compound. 34 The results of our study confirm that general impression because 12S-HETE was essentially devoid of vascular activity under these bioassay conditions ( figure 8 ). In marked contrast, its stereoisomer was a powerful vasodilator ( figure 8) .
The platelet 12-lipoxygenase pathway was the first lipoxygenase discovered in animal tissues and is the source of 12S-HETE.3s However, the lipoxygenase pathway is probably not the source of 12R-HETE, at least in humans.36 This stereoisomer is generated in relatively high yield by the cytochrome P450 monooxygenase system. Furthermore, 12R-HETE is the predominant stereoisomer found in the lesional scale of patients with psoriasis, which is relevant because an active cytochrome P450 system is well established in human skin.36
If 12R-HETE contributes to the inflammatory process accompanying psoriasis, or if 12R-HETE ac-counts for some of the responses that have been attributed to cytochrome P450 metabolites in the macro-and microcirculation, then it might be appropriate to reexamine the general impression that 12-HETE is a biologically inactive compound. Furthermore, if the actions of 5,6 EET are stereospecific, as are the vasodilator actions of 12-HETE (figure 8), then previous studies6' 7may have underestimated the potency of 5,6
EET.
It should be emphasized that enzyme inhibitor data should be interpreted with caution. Although a vasodilator action of cytochrome P450 metabolites could explain the postburn action of BW755c and ketoconazole, it will be difficult to enthusiastically support the idea that these novel AA metabolites are important determinants of vasomotor tone in any condition without further research. These substances must be detected in biological fluids and correlated with changes in tissue perfusion, and appropriate effects must be observed with specific receptor antagonists. Therefore, this explanation must be considered speculative at this time.
(5) Postburn vasomotor tone was mediated by a product not associated with AA, such as an amine (e.g., histamine, serotonin), peptide (e.g., bradykinin, interleukin 1), or factors released from migrating cells (e.g., cytotoxic enzymes, 02 radicals).
There is no question that a host of factors participate in the reaction evoked by experimental or clinical thermal injury. Biological fluids contain several of the above substances, and undoubtedly several unidentified substances with the potential to alter tissue perfusion. Some putative mediators originate in migrating cells and BW755c reduces leukocyte invasion into a site of inflammation.10-12 For this reason, the postburn vasodilator effect of BW755c (figures 1 and 2) does not necessarily implicate a vascular effect caused by a locally generated AA metabolite. On the other hand, the full expression of leukocyte-derived mediator effects usually requires several hours,12' 28, 37 and these present experiments were usually completed 1 to 2 hr after the thermal injury. There was no obvious effect of any treatment on the number of leukocytes that were observed after the burn in fixed stained specimens (see Results).
It is logical to assume that the contribution of most systemic factors was minimized by the relatively small injury burden, the local route of administration of the inhibitors, and the relatively short observation period. It should be reemphasized that most inflammatory injuries, especially burns, are mediated by complicated interactions between several systemic and local PROCTOR et a. mechanisms,1-3, 28, 29 whereas the technique used in this study purposely favored the contribution of local factors to the burn response. Furthermore, the cheek pouch is a relatively simple tissue that consists primarily of epithelium and interstitium, so these results might not directly relate to inflammatory injuries in more complex tissues. In summary, AA metabolites are probably not important determinants of resting vasomotor tone in the hamster cheek pouch microcirculation because three structurally and functionally dissimilar enzyme inhibitors had no effects on blood flow at concentrations that blocked the effects of AA. However, after thermal injury, BW755c and ketoconazole produced opposite effects on blood flow, while indomethacin continued to have no detectable effect. The responses could not be attributed to nonspecific alterations in vascular reactivity or to a breakthrough of enzyme inhibition, but the explanation is otherwise unknown. If the actions of the inhibitors were relatively specific, these results suggest that a nonprostaglandin vasodilator substance was important for the maintenance of postburn blood flow. This concept was supported by the vasodilation caused by two purified synthetic products from the cytochrome P450 pathway of AA metabolism. Nevertheless, product formation was not measured by a biochemical assay, so the contribution of other AA metabolites, and products not associated with AA, cannot be excluded.
